Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black purchased 43,492 shares of the business’s stock in a transaction that occurred on Thursday, May 18th. The shares were purchased at an average cost of $2.22 per share, with a total value of $96,552.24. Following the completion of the acquisition, the chief financial officer now directly owns 43,492 shares of the company’s stock, valued at $96,552.24. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Standard BioTools Stock Up 6.1 %
NASDAQ LAB opened at $2.43 on Tuesday. The stock has a market capitalization of $190.49 million, a P/E ratio of -1.46 and a beta of 1.54. Standard BioTools Inc. has a 52-week low of $0.92 and a 52-week high of $2.62. The firm has a 50-day moving average price of $1.87 and a 200 day moving average price of $1.73.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in LAB. Jane Street Group LLC purchased a new position in Standard BioTools in the third quarter valued at about $28,000. LMR Partners LLP purchased a new position in Standard BioTools in the third quarter valued at about $30,000. Barclays PLC purchased a new position in Standard BioTools in the first quarter valued at about $53,000. SMH Capital Advisors Inc. purchased a new position in Standard BioTools in the fourth quarter valued at about $26,000. Finally, Commonwealth Equity Services LLC increased its holdings in Standard BioTools by 94.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 30,082 shares of the company’s stock valued at $35,000 after buying an additional 14,630 shares in the last quarter. 63.17% of the stock is owned by hedge funds and other institutional investors.
About Standard BioTools
Standard BioTools Inc engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents.
- Get a free copy of the StockNews.com research report on Standard BioTools (LAB)
- monday.com Surges on Price and Volume after Blowout Results
- Can Ryanair Stock Fly Above Resistance Levels, What Earnings Show
- All Aboard! The Sell-Side Has Railroads In Reversal
- Is There Value Left in Lyft Stock?
- Everything About ZIM Integrated Screams Undervaluation
Receive News & Ratings for Standard BioTools Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Standard BioTools and related companies with MarketBeat.com's FREE daily email newsletter.